Latest News Archive
Please select Category, Year, and then Month to display items
17 May 2024
|
Story Anthony Mthembu
|
Photo Supplied
Prof Magdalena Sobon from Poland and Michael Jackson Blebo from Ghana shared their expertise with staff and students during their visit to the Department of Fine Arts at the University of the Free State.
In a concerted effort to solidify its identity in South Africa and abroad, the Department of Fine Arts at the University of the Free State (UFS) recently played host to two distinguished artists: Prof Magdalena Sobon from the Wladyslaw Strzeminski Academy of Fine Arts in Lodz, and the Ghanaian multidisciplinary artist, Michael Jackson Blebo.
Dr Adelheid Von Maltitz, Senior Lecturer in the Department of Fine Arts at UFS, lauded the visits, held between 19 and 29 March 2024, as an enriching learning experience for the faculty and students within the department.
The visit highlights
During their visit to UFS, Prof Sobon and Blebo actively engaged with the department’s staff and students. Prof Sobon, an acknowledged paper-making artist, conducted a comprehensive two-day workshop, imparting extensive knowledge in this craft. As a direct outcome of this workshop, the department has procured the requisite equipment and materials, enriching the students’ capabilities in this medium. Blebo on the other hand, conducted a demonstration on clay bust modelling and both artists participated in critique sessions with the fourth-year students. Dr Von Maltitz underlined the significance of Blebo’s African heritage, noting, ‘’For our students to interact with a young, accomplished artist of his calibre is of benefit to them in terms of how they may envision their art careers.’’ Of particular note were Prof Sobon’s interactions with the students, wherein she shared her own artistic practices from her student years during her lectures.
In addition to their engagements with the students, Prof Sobon and Blebo also had the opportunity to present their research to second-year sculpture students at the Richmond Land Art Project, an off-campus initiative fostering art creation centred on socio-economic and other pertinent issues.
Future collaborations
Dr Von Maltitz emphasised the importance of maintaining ties with these eminent artists for the department’s growth and global outreach. Prof Sobon’s visit has paved the way for two department members to visit the Wladyslaw Strzeminski Academy of Fine Arts in Lodz in the near future. ‘’These individuals will get an opportunity to learn about studio setups and network with fellow academics, creative researchers, and artists,’’ stated Dr Von Maltitz. She hailed the visit by the two artists as both stimulating and fruitful, particularly for the students.
National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Dr Derek Litthauer Photo: Supplied |
This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.
Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.
This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.
The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.